| Denville Anthony Myrie, MD | |
|
1800 Mulberry St, Scranton, PA 18510-2369 | |
| (570) 703-8123 | |
| Not Available |
| Full Name | Denville Anthony Myrie |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 32 Years |
| Location | 1800 Mulberry St, Scranton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588610539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD-34603 (Iowa) | Secondary |
| 208600000X | Surgery | 43644 (Iowa) | Secondary |
| 2086S0102X | Surgery - Surgical Critical Care | MD469998 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Johns Hospital | Springfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Springfield Clinic Llp | 0547166076 | 669 |
News Archive
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
The School of Science at Indiana University-Purdue University Indianapolis has launched the Institute for Mathematical Modeling and Computational Science, an interdisciplinary endeavor dedicated to solving perplexing problems in such diverse fields as medicine, the environment, and computer science. iM2CS's parallel mission is to train a new generation to identify and solve the scientific issues with which they will be faced.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013.
IQ Therapeutics B.V., Groningen, the Netherlands, announced this week that in collaboration with the University of Texas Medical Branch it has obtained outstanding results for the treatment of inhalation anthrax. In a rabbit model up to 100% survival could be achieved with extended time to treatment (48h post infection) with a combination of two specific monoclonal antibodies developed by IQ Therapeutics. This has significant potential for saving lives of infected people who have no immediate access to treatment.
› Verified 8 days ago
| Entity Name | Springfield Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780638478 PECOS PAC ID: 0547166076 Enrollment ID: O20040331000826 |
News Archive
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
The School of Science at Indiana University-Purdue University Indianapolis has launched the Institute for Mathematical Modeling and Computational Science, an interdisciplinary endeavor dedicated to solving perplexing problems in such diverse fields as medicine, the environment, and computer science. iM2CS's parallel mission is to train a new generation to identify and solve the scientific issues with which they will be faced.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013.
IQ Therapeutics B.V., Groningen, the Netherlands, announced this week that in collaboration with the University of Texas Medical Branch it has obtained outstanding results for the treatment of inhalation anthrax. In a rabbit model up to 100% survival could be achieved with extended time to treatment (48h post infection) with a combination of two specific monoclonal antibodies developed by IQ Therapeutics. This has significant potential for saving lives of infected people who have no immediate access to treatment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Denville Anthony Myrie, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Denville Anthony Myrie, MD 1800 Mulberry St, Scranton, PA 18510-2369 Ph: (570) 703-8123 |
News Archive
A drug first designed to prevent cancer cells from multiplying has a second effect: it switches immune cells that turn down the body's attack on tumors back into the kind that amplify it. This is the finding of a study led by researchers from NYU Langone Medical Center and published recently in Cancer Immunology Research.
The School of Science at Indiana University-Purdue University Indianapolis has launched the Institute for Mathematical Modeling and Computational Science, an interdisciplinary endeavor dedicated to solving perplexing problems in such diverse fields as medicine, the environment, and computer science. iM2CS's parallel mission is to train a new generation to identify and solve the scientific issues with which they will be faced.
Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013.
IQ Therapeutics B.V., Groningen, the Netherlands, announced this week that in collaboration with the University of Texas Medical Branch it has obtained outstanding results for the treatment of inhalation anthrax. In a rabbit model up to 100% survival could be achieved with extended time to treatment (48h post infection) with a combination of two specific monoclonal antibodies developed by IQ Therapeutics. This has significant potential for saving lives of infected people who have no immediate access to treatment.
› Verified 8 days ago
Fitzgerald Junior Casimir, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-7245 | |
Dr. Khaleel A Shaikh, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-346-7797 Fax: 570-342-9802 | |
John Andre Pepen, Surgery Medicare: Accepting Medicare Assignments Practice Location: 743 Jefferson Ave Ste 104, Scranton, PA 18510 Phone: 570-207-0433 | |
Dr. James J. Roche, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 225 Penn Ave, Scranton, PA 18503 Phone: 570-342-1643 Fax: 570-342-7119 | |
Dr. John Anthony Kutz, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-7355 Fax: 570-703-7354 | |
Monty Littlejohn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-7245 | |
Dr. Maryfrances Koester, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-7400 Fax: 570-703-7498 |